BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38600006)

  • 1. Guidelines for the management of coagulation disorders in patients with cirrhosis.
    Aiza-Haddad I; Cisneros-Garza LE; Morales-Gutiérrez O; Malé-Velázquez R; Rizo-Robles MT; Alvarado-Reyes R; Barrientos-Quintanilla LA; Betancourt-Sánchez F; Cerda-Reyes E; Contreras-Omaña R; Dehesa-Violante MB; Flores-García NC; Gómez-Almaguer D; Higuera-de la Tijera MF; Lira-Pedrin MA; Lira-Vera JE; Manzano-Cortés H; Meléndez-Mena DE; Muñoz-Ramírez MR; Pérez-Hernández JL; Ramos-Gómez MV; Sánchez-Ávila JF
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):144-162. PubMed ID: 38600006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
    Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
    J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.
    Rassi AB; d'Amico EA; Tripodi A; da Rocha TRF; Migita BY; Ferreira CM; Carrilho FJ; Farias AQ
    J Hepatol; 2020 Jan; 72(1):85-94. PubMed ID: 31536747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure.
    Intagliata NM; Davis JPE; Caldwell SH
    Semin Respir Crit Care Med; 2018 Oct; 39(5):598-608. PubMed ID: 30485890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in cirrhosis: a new paradigm?
    Leonardi F; Maria N; Villa E
    Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for managing coagulation disorders in liver disease.
    Stravitz RT
    Hepatol Int; 2018 Sep; 12(5):390-401. PubMed ID: 30066204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic alterations and management of haemostasis in patients with cirrhosis.
    Lisman T; Caldwell SH; Intagliata NM
    J Hepatol; 2022 Jun; 76(6):1291-1305. PubMed ID: 35589251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates.
    Northup P; Reutemann B
    Liver Transpl; 2018 Aug; 24(8):1119-1132. PubMed ID: 30142249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bleeding in patients with liver disease.
    Northup PG; Lisman T; Roberts LN
    J Thromb Haemost; 2021 Jul; 19(7):1644-1652. PubMed ID: 33974330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhotic coagulopathy: A rebalanced hemostasis.
    Singh AD; Mucha SR; Lindenmeyer CC
    Cleve Clin J Med; 2022 Sep; 89(9):523-533. PubMed ID: 37907441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
    Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
    J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions.
    Luther J; Friedman LS
    Clin Liver Dis; 2022 Feb; 26(1):1-12. PubMed ID: 34802655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?
    Yates SG; Gavva C; Agrawal D; Sarode R
    Transfusion; 2016 Apr; 56(4):791-8. PubMed ID: 26876945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Transfusion in Patients With Cirrhosis in China: A Retrospective Multicenter Cohort Study.
    Lu Y; Sun G; Liu X; Liu Z; Tan J; Hao Y; Shan G; Luo Q; Wang D; Xing Y; Zhang X; Gong J; Stanworth SJ; Wang J; Wen A
    Transfus Med Rev; 2017 Apr; 31(2):107-112. PubMed ID: 28063764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coagulopathy of liver disease: a shift in thinking.
    Ballantine A; Martin D; Thakrar SV
    Br J Hosp Med (Lond); 2021 Jun; 82(6):1-9. PubMed ID: 34191571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostasis, coagulation abnormalities, and liver disease.
    Mackavey CL; Hanks R
    Crit Care Nurs Clin North Am; 2013 Dec; 25(4):435-46, v. PubMed ID: 24267280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.